Technologies Available for Licensing
TWO PHASE BIOACTIVE FORMULATIONS
The present invention relates to two phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the bioactive ingredient that is similar to the bioactive ingredient when in the solid state. The bioactive ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor. The bio active ingredient comprises 1,1'-methlyenebis[4-[(hydroxyimino)methyl]-pyridinium]dimethane- sulfonate.
Docket:CBMS 2009-42
Publication/Issued No.:8,722,706
Publication/Issue Date:2015-05-13
Categories: Method
More Detail:Visit USPTO.GOV
Lab:CBMS
Inventor(s):UNDERWOOD, P.; DIXON, H.; MCDONOUGH, J.; CABELL, L.